[Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis]. 2016

L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
Myasnikov Clinical Cardiology Institute, Russian Cardiology Research Center, Moscow, Russia.

Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with high risk of cardiovascular events. Among main causes of death in RA are: myocardial infarction, cerebrovascular accident, sudden cardiac death, which are determined by the early development and rapid progression of atherosclerotic vascular lesions. According to studies high risk of cardiovascular events is not explained by only classical risk factors. It is assumed that there are additional mechanisms of development of adverse outcomes such as systemic inflammation, increased arterial stiffness, and endothelial dysfunction. In this literature review we present various risk factors of cardiovascular events in patients with RA and their relation to RA pathogenesis.

UI MeSH Term Description Entries
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
October 2006, Zeitschrift fur Rheumatologie,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
May 2024, Current opinion in rheumatology,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
January 2012, Current pharmaceutical design,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
May 2010, Rheumatic diseases clinics of North America,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
December 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
January 2022, Frontiers in immunology,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
December 2023, Medicina (Kaunas, Lithuania),
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
May 2011, Annals of the rheumatic diseases,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
January 2012, Klinicheskaia meditsina,
L B Krougly, and O A Fomicheva, and Yu A Karpov, and T V Popkova, and D S Novikova, and E L Nasonov
January 2003, The Journal of rheumatology,
Copied contents to your clipboard!